CAMDEN NATIONAL BANK - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.

Quarter-by-quarter ownership
CAMDEN NATIONAL BANK ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$6,828,287
+0.2%
67,036
-0.7%
1.40%
+5.1%
Q2 2023$6,814,150
+7.8%
67,527
-1.7%
1.33%
+4.0%
Q1 2023$6,320,492
+102074.1%
68,701
+0.8%
1.28%
-0.7%
Q4 2022$6,186
-99.9%
68,182
-0.4%
1.29%
+11.2%
Q3 2022$5,202,000
-9.7%
68,443
+0.5%
1.16%
-2.4%
Q2 2022$5,759,000
-1.2%
68,135
+2.6%
1.19%
+12.6%
Q1 2022$5,828,000
+0.8%
66,411
+0.4%
1.06%
+3.9%
Q4 2021$5,784,000
+6.2%
66,126
-0.7%
1.02%
-3.2%
Q3 2021$5,448,000
-8.4%
66,614
+2.2%
1.05%
-6.5%
Q2 2021$5,946,000
+5.7%
65,175
-0.9%
1.12%
+0.2%
Q1 2021$5,624,000
-10.3%
65,789
-0.9%
1.12%
-14.1%
Q4 2020$6,271,000
+4.6%
66,408
-3.7%
1.30%
-1.4%
Q3 2020$5,995,000
+0.4%
68,936
+0.8%
1.32%
-10.6%
Q2 2020$5,974,000
+6.2%
68,400
+0.2%
1.48%
-3.2%
Q1 2020$5,626,000
-22.9%
68,233
-11.4%
1.53%
+3.6%
Q4 2019$7,295,000
+12.8%
77,039
+3.5%
1.48%
+5.1%
Q3 2019$6,467,000
-3.8%
74,420
+1.1%
1.40%
-9.3%
Q2 2019$6,722,000
-4.3%
73,611
+0.8%
1.55%
-8.8%
Q1 2019$7,022,000
+13.2%
73,038
+1.1%
1.70%
-0.6%
Q4 2018$6,201,000
+5.1%
72,261
+5.6%
1.71%
+17.5%
Q3 2018$5,898,000
+18.5%
68,453
+3.9%
1.45%
+10.7%
Q2 2018$4,979,000
+3.8%
65,905
+11.1%
1.31%
-5.6%
Q1 2018$4,796,000
-2.1%
59,319
+1.6%
1.39%
-2.2%
Q4 2017$4,900,000
-0.6%
58,357
+1.6%
1.42%
-2.5%
Q3 2017$4,928,000
+6.3%
57,411
+3.4%
1.46%
+2.5%
Q2 2017$4,635,000
+22.9%
55,538
+9.4%
1.42%
+22.4%
Q1 2017$3,770,000
+7.3%
50,765
+5.3%
1.16%
+7.5%
Q4 2016$3,512,00048,2161.08%
Other shareholders
NOVARTIS A G shareholders Q1 2019
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders